HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anna Cozzi Selected Research

Apoferritins

4/2021Pathogenic mechanism and modeling of neuroferritinopathy.
11/2019Stem Cell Modeling of Neuroferritinopathy Reveals Iron as a Determinant of Senescence and Ferroptosis during Neuronal Aging.
9/2015A novel neuroferritinopathy mouse model (FTL 498InsTC) shows progressive brain iron dysregulation, morphological signs of early neurodegeneration and motor coordination deficits.
8/2013Human L-ferritin deficiency is characterized by idiopathic generalized seizures and atypical restless leg syndrome.
4/2010Mutant ferritin L-chains that cause neurodegeneration act in a dominant-negative manner to reduce ferritin iron incorporation.
1/2010Oxidative stress and cell death in cells expressing L-ferritin variants causing neuroferritinopathy.
9/2006Characterization of the l-ferritin variant 460InsA responsible of a hereditary ferritinopathy disorder.
6/2005Characterization of nuclear ferritin and mechanism of translocation.
6/2005Neuroferritinopathy: a neurodegenerative disorder associated with L-ferritin mutation.
10/2003Identification of two novel mutations in the 5'-untranslated region of H-ferritin using denaturing high performance liquid chromatography scanning.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anna Cozzi Research Topics

Disease

6Movement Disorders (Movement Disorder)
04/2021 - 06/2005
6Neuroferritinopathy
04/2021 - 06/2005
4Pantothenate Kinase-Associated Neurodegeneration (Hallervorden-Spatz Disease)
05/2020 - 09/2012
4Neurodegenerative Diseases (Neurodegenerative Disease)
10/2016 - 06/2005
3Iron Overload
01/2022 - 10/2003
3Neurodegeneration with brain iron accumulation (NBIA)
04/2021 - 12/2012
2Sideroblastic Anemia
10/2011 - 10/2004
2Friedreich Ataxia (Friedreich's Ataxia)
01/2009 - 10/2004
1Hemolysis
01/2018
1Thalassemia
01/2018
1Mitochondrial Diseases (Mitochondrial Disease)
10/2016
1Inborn Genetic Diseases (Disease, Hereditary)
09/2015
1Seizures (Absence Seizure)
08/2013
1Restless Legs Syndrome (Restless Legs)
08/2013
1Starvation
10/2011
1Refractory Anemia
10/2011
1Neuroblastoma
01/2010
1Astrocytoma (Pilocytic Astrocytoma)
06/2005
1Basal Ganglia Diseases (Basal Ganglia Disease)
06/2005
1Hyperferritinemia
10/2003
1hereditary Hyperferritinemia with congenital cataracts
10/2003

Drug/Important Bio-Agent (IBA)

14IronIBA
04/2021 - 10/2003
10ApoferritinsIBA
04/2021 - 10/2003
5Ferritins (Ferritin)IBA
04/2021 - 10/2003
4NucleotidesIBA
04/2010 - 06/2005
2Coenzyme A (CoA)IBA
01/2022 - 12/2012
2FrataxinIBA
01/2009 - 10/2004
2Messenger RNA (mRNA)IBA
06/2005 - 10/2003
1CalciumIBA
05/2020
1pantothenate kinaseIBA
12/2012
1Reactive Oxygen Species (Oxygen Radicals)IBA
10/2011
1Proteins (Proteins, Gene)FDA Link
10/2011
1Protein SIBA
01/2010
1EnzymesIBA
01/2009
1Peptides (Polypeptides)IBA
09/2006
1Amino AcidsFDA Link
06/2005
1Mitochondrial DNA (mtDNA)IBA
10/2004
1Mitochondrial Proteins (Mitochondrial Protein)IBA
10/2004
15' Untranslated Regions (5' UTR)IBA
10/2003

Therapy/Procedure

1Therapeutics
10/2016